FOLH1 and neoplasm: Kratochwil et al. performed a retrospective analysis [19] to quantify the uptake of [68Ga]Ga-DOTA-FAPi-04 in 80 patients with 28 different tumour entities (confirmed by histopathological or unequivocal radiologic findings), including 4 PSMA-negative PCa cases.